Previous Close | 50.14 |
1-Year Change | 65.81% |
6-Months Change | 66.47% |
3-Months Change | 24.14% |
Moving Avg (50d) | 43.889 |
Moving Avg (200d) | 33.894 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 2.28B |
Beta (3-Years) | 1 |
Revenue Growth (ttm) | -9.42% |
Net Profit Margin (ttm) | -2.9% |
Return On Assets (ttm) | -1.55% |
EPS (ttm) | -0.74 |
PE Ratio (ttm) | -67.76 |
Dividend Yield | % |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Services |
Country: | United States |
Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, California. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth. Wikipedia